Senores Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENORES PHARMS
SENORES PHARMS has fifty-two approved drugs.
Summary for Senores Pharms
| US Patents: | 0 |
| Tradenames: | 47 |
| Ingredients: | 47 |
| NDAs: | 52 |
Drugs and US Patents for Senores Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senores Pharms | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 076802-002 | Oct 6, 2005 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Senores Pharms | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 215629-001 | Jun 20, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Senores Pharms | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 214088-002 | Apr 7, 2022 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
